Maynard Um
-
-
-
-
-
-
-
Pfizer reafffirms 2026 guidance after CFO transition announcement
-
-
-
-
-
-
-
Pfizer drug combination cuts prostate cancer progression risk by 52%
-
-
-
-
-
-
-
FDA Commissioner Marty Makary to step down - Politico
-
-
-
-
-
-
-
Pfizer Reviewing New Molecule It Designed Using AI - CEO
-
-
-
-
-
-
-
Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
-
-
-
-
-
-
-
Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
-
-
-
-
-
-
-
Pfizer (PFE) PT Lowered to $26 at BofA Securities
-
412,030 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

